{"id":21873,"date":"2013-08-26T13:16:06","date_gmt":"2013-08-26T17:16:06","guid":{"rendered":"http:\/\/www.ino.com\/blog\/?p=21873"},"modified":"2013-08-26T13:16:06","modified_gmt":"2013-08-26T17:16:06","slug":"todays-video-update-amgen-moves-into-the-big-business-of-cancer-drugs","status":"publish","type":"post","link":"https:\/\/wwwtest.ino.com\/blog\/2013\/08\/todays-video-update-amgen-moves-into-the-big-business-of-cancer-drugs\/","title":{"rendered":"Today's Video Update: Amgen moves into the big business of cancer drugs"},"content":{"rendered":"

\"\"<\/a>Hello traders everywhere! Adam Hewison here, President of INO.com and Co-creator of MarketClub, with your mid-day market update<\/a><\/strong> for Monday, the 26th of August.<\/p>\n

The big news today is that Amgen (NASDAQ:AMGN)<\/a> has agreed to buy Onyx Pharmaceuticals (NASDAQ:ONXX)<\/a> for $10.4 billion. Amgen, the world's biggest biotechnology company, was missing from one of the biggest and fastest growing markets, cancer drugs. With the acquisition of Onyx Pharmaceuticals, Amgen will gain access to the company's three anticancer treatments. I will be analyzing Amgen today using our Trade Triangle technology and will share with you the trading results for the year so far.<\/p>\n

On Friday, I talked about Microsoft (NASDAQ:MSFT)<\/a> and the fact that the CEO Steve Ballmer was leaving the company. Here is a stock that has gone nowhere in 10 years, and no matter who takes over, it is going to take a long time to extricate themselves from many of the complexities of that business. I see this stock going nowhere in a hurry.<\/p>\n

Don't let anybody tell you that there is no money in electric cars. Tesla (NASDAQ:TSLA)<\/a> as a company is now worth over $20 billion!!<\/p>\n

You can hear me talking about retail stocks in a recent interview I did on CNBC. You may enjoy hearing what I have say. Watch it here.<\/a><\/p>\n

Have a great trading day,
\nAdam Hewison<\/a>
\nPresident, INO.com
\nCo-Creator, MarketClub<\/p>\n

Recent Special Videos:<\/span>
\nWashington Post<\/a>
\nCrude Oil<\/a>
\nCandlestick Charts<\/a>
\nApple (NASDAQ:AAPL)<\/a>
\nNetflix (NASDAQ:NFLX)<\/a><\/p>\n

\"Bloomberg\"<\/a> \"BNN\"<\/a> \"CNBC\"<\/a> \"FOX\"<\/a><\/p>\n

Adam appears frequently on the following financial news channels as a guest expert. Click on any cable logo to watch Adam's latest appearance.<\/strong><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Hello traders everywhere! Adam Hewison here, President of INO.com and Co-creator of MarketClub, with your mid-day market update for Monday, the 26th of August. The big news today is that Amgen (NASDAQ:AMGN) has agreed to buy Onyx Pharmaceuticals (NASDAQ:ONXX) for $10.4 billion. Amgen, the world's biggest biotechnology company, was missing from one of the biggest […]<\/p>\n","protected":false},"author":41,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[4071,188,5499,28,3839,310,3831,1069,147,1768,5492,307,5500,7947,4053],"class_list":["post-21873","post","type-post","status-publish","format-standard","hentry","category-trading-videos","tag-8-95-trial","tag-adam-hewison","tag-amgen-inc-nasdaqamgn","tag-crude-oil","tag-donchian-channel","tag-dow","tag-dx","tag-euro","tag-fibonacci-resistance","tag-marketclub-tips-talk","tag-microsoft-nasdaqmsft","tag-precious-metals","tag-tesla-nasdaqtsla","tag-trading-videos","tag-williamr"],"yoast_head":"\nToday's Video Update: Amgen moves into the big business of cancer drugs - INO.com Trader's Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ino.com\/blog\/2013\/08\/todays-video-update-amgen-moves-into-the-big-business-of-cancer-drugs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Today's Video Update: Amgen moves into the big business of cancer drugs - INO.com Trader's Blog\" \/>\n<meta property=\"og:description\" content=\"Hello traders everywhere! Adam Hewison here, President of INO.com and Co-creator of MarketClub, with your mid-day market update for Monday, the 26th of August. The big news today is that Amgen (NASDAQ:AMGN) has agreed to buy Onyx Pharmaceuticals (NASDAQ:ONXX) for $10.4 billion. Amgen, the world's biggest biotechnology company, was missing from one of the biggest […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ino.com\/blog\/2013\/08\/todays-video-update-amgen-moves-into-the-big-business-of-cancer-drugs\/\" \/>\n<meta property=\"og:site_name\" content=\"INO.com Trader's Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/inocom\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-08-26T17:16:06+00:00\" \/>\n<meta name=\"author\" content=\"The INO.com Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"The INO.com Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.ino.com\/blog\/2013\/08\/todays-video-update-amgen-moves-into-the-big-business-of-cancer-drugs\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ino.com\/blog\/2013\/08\/todays-video-update-amgen-moves-into-the-big-business-of-cancer-drugs\/\"},\"author\":{\"name\":\"The INO.com Team\",\"@id\":\"https:\/\/www.ino.com\/blog\/#\/schema\/person\/d86a8cce826b7bd105200d88bb28a280\"},\"headline\":\"Today's Video Update: Amgen moves into the big business of cancer drugs\",\"datePublished\":\"2013-08-26T17:16:06+00:00\",\"dateModified\":\"2013-08-26T17:16:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ino.com\/blog\/2013\/08\/todays-video-update-amgen-moves-into-the-big-business-of-cancer-drugs\/\"},\"wordCount\":280,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.ino.com\/blog\/#organization\"},\"keywords\":[\"8.95 Trial\",\"adam hewison\",\"Amgen Inc. (NASDAQ:AMGN)\",\"Crude Oil\",\"Donchian Channel\",\"dow\",\"DX\",\"euro\",\"fibonacci resistance\",\"MarketClub Tips & Talk\",\"Microsoft (NASDAQ:MSFT)\",\"precious metals\",\"Tesla (NASDAQ:TSLA)\",\"Trading Videos\",\"William%R\"],\"articleSection\":[\"Trading Videos\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.ino.com\/blog\/2013\/08\/todays-video-update-amgen-moves-into-the-big-business-of-cancer-drugs\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ino.com\/blog\/2013\/08\/todays-video-update-amgen-moves-into-the-big-business-of-cancer-drugs\/\",\"url\":\"https:\/\/www.ino.com\/blog\/2013\/08\/todays-video-update-amgen-moves-into-the-big-business-of-cancer-drugs\/\",\"name\":\"Today's Video Update: Amgen moves into the big business of cancer drugs - INO.com Trader's Blog\",\"isPartOf\":{\"@id\":\"https:\/\/www.ino.com\/blog\/#website\"},\"datePublished\":\"2013-08-26T17:16:06+00:00\",\"dateModified\":\"2013-08-26T17:16:06+00:00\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ino.com\/blog\/2013\/08\/todays-video-update-amgen-moves-into-the-big-business-of-cancer-drugs\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ino.com\/blog\/#website\",\"url\":\"https:\/\/www.ino.com\/blog\/\",\"name\":\"INO.com Trader's Blog\",\"description\":\"Expert Charts, Trading Tips and Technical Analysis from INO.com\",\"publisher\":{\"@id\":\"https:\/\/www.ino.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ino.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ino.com\/blog\/#organization\",\"name\":\"INO.com Trader's Blog\",\"url\":\"https:\/\/www.ino.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ino.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ino.com\/blog\/wp-content\/uploads\/2018\/12\/inologo-400.jpg\",\"contentUrl\":\"https:\/\/www.ino.com\/blog\/wp-content\/uploads\/2018\/12\/inologo-400.jpg\",\"width\":400,\"height\":472,\"caption\":\"INO.com Trader's Blog\"},\"image\":{\"@id\":\"https:\/\/www.ino.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/inocom\/\",\"https:\/\/www.linkedin.com\/company-beta\/1056449\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ino.com\/blog\/#\/schema\/person\/d86a8cce826b7bd105200d88bb28a280\",\"name\":\"The INO.com Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ino.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/cb06ce065c1db526fc31f4d08d898a30?s=96&d=identicon&r=pg\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/cb06ce065c1db526fc31f4d08d898a30?s=96&d=identicon&r=pg\",\"caption\":\"The INO.com Team\"},\"url\":\"https:\/\/wwwtest.ino.com\/blog\/author\/the-ino-com-team\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Today's Video Update: Amgen moves into the big business of cancer drugs - INO.com Trader's Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ino.com\/blog\/2013\/08\/todays-video-update-amgen-moves-into-the-big-business-of-cancer-drugs\/","og_locale":"en_US","og_type":"article","og_title":"Today's Video Update: Amgen moves into the big business of cancer drugs - INO.com Trader's Blog","og_description":"Hello traders everywhere! Adam Hewison here, President of INO.com and Co-creator of MarketClub, with your mid-day market update for Monday, the 26th of August. The big news today is that Amgen (NASDAQ:AMGN) has agreed to buy Onyx Pharmaceuticals (NASDAQ:ONXX) for $10.4 billion. Amgen, the world's biggest biotechnology company, was missing from one of the biggest […]","og_url":"https:\/\/www.ino.com\/blog\/2013\/08\/todays-video-update-amgen-moves-into-the-big-business-of-cancer-drugs\/","og_site_name":"INO.com Trader's Blog","article_publisher":"https:\/\/www.facebook.com\/inocom\/","article_published_time":"2013-08-26T17:16:06+00:00","author":"The INO.com Team","twitter_card":"summary_large_image","twitter_misc":{"Written by":"The INO.com Team","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ino.com\/blog\/2013\/08\/todays-video-update-amgen-moves-into-the-big-business-of-cancer-drugs\/#article","isPartOf":{"@id":"https:\/\/www.ino.com\/blog\/2013\/08\/todays-video-update-amgen-moves-into-the-big-business-of-cancer-drugs\/"},"author":{"name":"The INO.com Team","@id":"https:\/\/www.ino.com\/blog\/#\/schema\/person\/d86a8cce826b7bd105200d88bb28a280"},"headline":"Today's Video Update: Amgen moves into the big business of cancer drugs","datePublished":"2013-08-26T17:16:06+00:00","dateModified":"2013-08-26T17:16:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ino.com\/blog\/2013\/08\/todays-video-update-amgen-moves-into-the-big-business-of-cancer-drugs\/"},"wordCount":280,"commentCount":0,"publisher":{"@id":"https:\/\/www.ino.com\/blog\/#organization"},"keywords":["8.95 Trial","adam hewison","Amgen Inc. (NASDAQ:AMGN)","Crude Oil","Donchian Channel","dow","DX","euro","fibonacci resistance","MarketClub Tips & Talk","Microsoft (NASDAQ:MSFT)","precious metals","Tesla (NASDAQ:TSLA)","Trading Videos","William%R"],"articleSection":["Trading Videos"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.ino.com\/blog\/2013\/08\/todays-video-update-amgen-moves-into-the-big-business-of-cancer-drugs\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.ino.com\/blog\/2013\/08\/todays-video-update-amgen-moves-into-the-big-business-of-cancer-drugs\/","url":"https:\/\/www.ino.com\/blog\/2013\/08\/todays-video-update-amgen-moves-into-the-big-business-of-cancer-drugs\/","name":"Today's Video Update: Amgen moves into the big business of cancer drugs - INO.com Trader's Blog","isPartOf":{"@id":"https:\/\/www.ino.com\/blog\/#website"},"datePublished":"2013-08-26T17:16:06+00:00","dateModified":"2013-08-26T17:16:06+00:00","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ino.com\/blog\/2013\/08\/todays-video-update-amgen-moves-into-the-big-business-of-cancer-drugs\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.ino.com\/blog\/#website","url":"https:\/\/www.ino.com\/blog\/","name":"INO.com Trader's Blog","description":"Expert Charts, Trading Tips and Technical Analysis from INO.com","publisher":{"@id":"https:\/\/www.ino.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ino.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ino.com\/blog\/#organization","name":"INO.com Trader's Blog","url":"https:\/\/www.ino.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ino.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.ino.com\/blog\/wp-content\/uploads\/2018\/12\/inologo-400.jpg","contentUrl":"https:\/\/www.ino.com\/blog\/wp-content\/uploads\/2018\/12\/inologo-400.jpg","width":400,"height":472,"caption":"INO.com Trader's Blog"},"image":{"@id":"https:\/\/www.ino.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/inocom\/","https:\/\/www.linkedin.com\/company-beta\/1056449\/"]},{"@type":"Person","@id":"https:\/\/www.ino.com\/blog\/#\/schema\/person\/d86a8cce826b7bd105200d88bb28a280","name":"The INO.com Team","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ino.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/cb06ce065c1db526fc31f4d08d898a30?s=96&d=identicon&r=pg","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/cb06ce065c1db526fc31f4d08d898a30?s=96&d=identicon&r=pg","caption":"The INO.com Team"},"url":"https:\/\/wwwtest.ino.com\/blog\/author\/the-ino-com-team\/"}]}},"_links":{"self":[{"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/posts\/21873"}],"collection":[{"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/users\/41"}],"replies":[{"embeddable":true,"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/comments?post=21873"}],"version-history":[{"count":0,"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/posts\/21873\/revisions"}],"wp:attachment":[{"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/media?parent=21873"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/categories?post=21873"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/tags?post=21873"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}